financetom
Business
financetom
/
Business
/
--Johnson Controls Keeps Quarterly Dividend at $0.37 a Share, Payable April 19 to Shareholders of Record March 25
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Johnson Controls Keeps Quarterly Dividend at $0.37 a Share, Payable April 19 to Shareholders of Record March 25
Mar 13, 2024 7:28 AM

10:12 AM EDT, 03/13/2024 (MT Newswires) --

Price: 62.07, Change: +0.08, Percent Change: +0.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Credo, TE Connectivity Finalize Settlement in Active Electrical Cable Disputes
Credo, TE Connectivity Finalize Settlement in Active Electrical Cable Disputes
Mar 27, 2026
09:29 AM EDT, 03/27/2026 (MT Newswires) -- Credo Technology Group ( CRDO ) and TE Connectivity ( TEL ) said Friday the companies have reached a license and settlement agreement related to active electrical cable technology. The companies said all lawsuits between them will be promptly dismissed under the agreement. Financial terms of the settlement were not disclosed. Credo Technology...
Braskem Q4 Net Loss Widens, Gross Revenue Decreases
Braskem Q4 Net Loss Widens, Gross Revenue Decreases
Mar 27, 2026
09:02 AM EDT, 03/27/2026 (MT Newswires) -- Braskem ( BAK ) reported Friday a Q4 net loss attributable to the company's shareholders of 10.28 billion Brazilian reais ($1.95 billion), widening from a loss of 5.65 billion reais a year earlier. Gross revenue for the quarter ended Dec. 31 was 18.30 billion reais, down from 22.44 billion reais a year earlier....
Why Is Rocket Pharma Stock Soaring Friday?
Why Is Rocket Pharma Stock Soaring Friday?
Mar 27, 2026
Rocket Pharmaceuticals Inc. ( RCKT ) shares are up during Friday’s premarket session following the FDA’s accelerated approval of Kresladi (marnetegragene autotemcel), the first gene therapy for children with severe leukocyte adhesion deficiency-I (LAD-I). FDA Accelerated Approval Drives Investor Sentiment This significant development is boosting investor sentiment as the company aims to enhance financial flexibility through the monetization of a...
Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries
Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries
Mar 27, 2026
March 27 (Reuters) - Medtronic ( MDT ) said on Friday the U.S. Food and Drug Administration has cleared its surgical system for use in cranial and ear, nose and throat procedures, expanding the platform beyond the spine indication it received earlier this year. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved